000963.SZ · 华东医药
China A-shares · RS rating 20 · As of 2026-10-14
| Price | 26.31 CNY |
|---|---|
| 1-day change | -1.0% |
| RS rating (overall / 1M / 3M / 12M) | 20 / 62 / 35 / 16 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 23 / 17 / 18 |
| Industry group (rank) | Medical-Generic Drugs (40) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | -2.7% |
| Distance from 52-week high | +39.7% |
| Market cap (USD) | $7.2B |